A new blood test for pregnant women detects with 75-80% accuracy whether their pregnancies will end in premature birth. The technique can also be used to estimate a fetus’ gestational age — or the mother’s due date — as reliably as and less expensively than ultrasound.
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
Despite the availability of hepatitis C treatment and changes in restrictions of these therapies, private insurance companies and even public payers like Medicaid and Medicare are still refusing to pay for it.
FDA commissioner, Scott Gottlieb said that he expects the FDA to approve 40 gene therapies by 2022 in a fireside chat at the 2018 BIO International Convention.
The study of viral ecology is taking major leaps forward with the use of long-read sequencing and viral metagenomics. On this webinar we discuss how MinION technology is bringing scientists closer to high-throughput single-virus genomics from environmental samples.
The genomes of more than 3000 of these bacteria have been mapped by scientists in order to better understand diseases and the mechanisms of antibiotic resistance.
A new study provides a unique look at a novel strategy — clinical trials in a dish — that bridges preclinical testing and clinical trials.
Some regulatory hurdles for makers of direct-to-consumer genetic health risk test have been lifted by the US Food and Drug Administration.
A security breach at DNA testing website MyHeritage have leaked the data of over 92 million users, the company said on Monday.
Yesterday’s news about the Oncotype DX test that could enable a lot of patients with breast cancer to safely forgo chemotherapy, is massive news for the breast cancer field. But it’s also big news for Genomic Health, the developer of the test.
A patient with metastatic breast cancer has made a dramatic recovery after receiving a personalised therapy using her own cells.
New findings suggest that a person’s own immune system helps nudge him or her down the path toward Parkinson’s, and that restraining the immune system with drugs potentially could prevent the neurological disorder.